共 31 条
[3]
[Anonymous], GUID SEL PROSTH PRIM
[5]
Briggs AH, 1999, HEALTH ECON, V8, P257, DOI 10.1002/(SICI)1099-1050(199905)8:3<257::AID-HEC427>3.0.CO
[6]
2-E
[9]
Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis
[J].
BRITISH MEDICAL JOURNAL,
2003, 326 (7388)
:522-525
[10]
Claxton K, 1996, HEALTH ECON, V5, P513, DOI 10.1002/(SICI)1099-1050(199611)5:6<513::AID-HEC237>3.0.CO